STANDARD BIOTOOLS INC. (LAB) Operating margin 2016–2025
STANDARD BIOTOOLS INC. (LAB) operating margin by fiscal year — reported operating income divided by reported revenue.
-129.2%FY2025 · since FY2016: -70.1% → -129.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -129.2% | +10.9 pp |
| FY2024 | -140.1% | -68.0 pp |
| FY2023 | -72.0% | +46.6 pp |
| FY2022 | -118.6% | -67.0 pp |
| FY2021 | -51.7% | -14.7 pp |
| FY2020 | -36.9% | +7.3 pp |
| FY2019 | -44.2% | -1.6 pp |
| FY2018 | -42.6% | +14.6 pp |
| FY2017 | -57.3% | +12.8 pp |
| FY2016 | -70.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice